全文获取类型
收费全文 | 23863篇 |
免费 | 2327篇 |
国内免费 | 314篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 474篇 |
妇产科学 | 269篇 |
基础医学 | 1897篇 |
口腔科学 | 395篇 |
临床医学 | 2603篇 |
内科学 | 3230篇 |
皮肤病学 | 213篇 |
神经病学 | 1128篇 |
特种医学 | 641篇 |
外科学 | 1932篇 |
综合类 | 3194篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 5119篇 |
眼科学 | 257篇 |
药学 | 2479篇 |
13篇 | |
中国医学 | 1623篇 |
肿瘤学 | 921篇 |
出版年
2024年 | 56篇 |
2023年 | 685篇 |
2022年 | 958篇 |
2021年 | 1507篇 |
2020年 | 1381篇 |
2019年 | 1945篇 |
2018年 | 1512篇 |
2017年 | 1161篇 |
2016年 | 827篇 |
2015年 | 797篇 |
2014年 | 1609篇 |
2013年 | 1641篇 |
2012年 | 1138篇 |
2011年 | 1274篇 |
2010年 | 949篇 |
2009年 | 888篇 |
2008年 | 863篇 |
2007年 | 788篇 |
2006年 | 700篇 |
2005年 | 579篇 |
2004年 | 473篇 |
2003年 | 398篇 |
2002年 | 311篇 |
2001年 | 236篇 |
2000年 | 173篇 |
1999年 | 126篇 |
1998年 | 106篇 |
1997年 | 95篇 |
1996年 | 78篇 |
1995年 | 75篇 |
1994年 | 85篇 |
1993年 | 66篇 |
1992年 | 55篇 |
1991年 | 55篇 |
1990年 | 44篇 |
1989年 | 61篇 |
1987年 | 51篇 |
1985年 | 233篇 |
1984年 | 325篇 |
1983年 | 286篇 |
1982年 | 286篇 |
1981年 | 268篇 |
1980年 | 223篇 |
1979年 | 205篇 |
1978年 | 148篇 |
1977年 | 154篇 |
1976年 | 181篇 |
1975年 | 145篇 |
1974年 | 108篇 |
1973年 | 101篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
31.
32.
目的系统整合男性对配偶围产期丧失体验的质性研究,为制订相关心理干预措施提供依据。方法检索中国生物医学文献数据库、中国知网、PubMed、Web of Science、CINAHL、PsychINFO、Embase、Cochrane Library数据库及数据平台中有关男性对配偶围产期丧失体验的质性研究,检索时限为建库至2021年4月。使用澳大利亚乔安娜布里格斯研究所循证卫生保健中心质性研究质量评价工具进行评价,采用汇集性整合方法进行整合分析。结果共纳入12篇文献,提炼出59个研究结果,归纳成11个类别,综合形成5个整合结果:存在多重情感体验、生活产生消极改变、采取不同类型的应对策略、面临的困境及需求、围产期丧失带来的益处。结论医护人员应打破对男性角色的刻板认知,积极关注男性对配偶围产期丧失的情感体验,联合家庭及医院,提供信息、环境、人文支持,减轻男性的照护压力,降低配偶围产期丧失对男性生活的消极影响,促进其个人成长。 相似文献
33.
《Archives of physical medicine and rehabilitation》2022,103(8):1684-1692
Conducting high-quality clinical research is dependent on merging scientific rigor with the clinical environment. This is often a complex endeavor that may include numerous barriers and competing interests. Overcoming these challenges and successfully integrating clinical research programs into clinical practice settings serving rehabilitation outpatients is beneficial from both a logistical perspective (eg, supports efficient and successful research procedures) and the establishment of a truly patient-centered research approach. Leveraging our experience with navigating this research-clinical care relationship, this article (1) proposes the Patient-Centered Framework for Rehabilitation Research, a model for integrating patient-centered research in an outpatient clinical setting that incorporates a collaborative, team-based model encompassing patient-centered values, as well as strategies for recruitment and retention, with a focus on populations living with disabilities or chronic diseases; (2) describes application of this framework in a comprehensive specialty multiple sclerosis center with both general strategies and specific examples to guide adaptation and implementation in other settings; and (3) discusses the effect of the framework as a model in 1 center, as well as the need for additional investigation and adaptation for other populations. The 5 interconnected principles incorporated in the Framework and which prioritize patient-centeredness include identifying shared values, partnering with the clinical setting, engaging with the population, building relationships with individuals, and designing accessible procedures. The Patient-Centered Framework for Rehabilitation Research is a model presented as an adaptable roadmap to guide researchers in hopes of not only improving individual patients’ experiences but also the quality and relevance of rehabilitation research as a whole. Future investigation is needed to test the Framework in other settings. 相似文献
34.
35.
36.
目的:通过小范围的临床实践,使用数据包络分析(data envelopment analysis,DEA)方法对基于全程化抗栓药学服务模式的华法林抗凝管理工作效率进行评价。方法:选取2021年7-12月南京大学医学院附属鼓楼医院心胸外科瓣膜置换术后使用华法林抗凝的患者。将患者分为实验组和对照组,实验组由临床药师利用基于分级管理的全程化抗栓药学服务模式进行抗凝管理和药学监护,对照组由临床药师按照无差别监护模式进行抗凝管理和监护,记录2种模式下药师工作内容和工作成效,通过DEA方法分析比较2种抗凝管理模式的效率。结果:研究最终纳入服用华法林的患者233人(实验组116人,对照组117人),实验组的单位患者管理时间显著减少[(27.8±9.7)min vs.(34.8±11.4)min]。经模型计算后,实验组的总体效率值为1,说明其投入和产出最优,且效率高于对照组。结论:全程化抗栓药学服务模式下药师管理单位抗凝患者需要的时间更少,管理效率更高。 相似文献
37.
《Vaccine》2022,40(24):3380-3388
BackgroundWe evaluated the safety and immunogenicity of NVX-CoV2373, a recombinant SARS-CoV-2 nanoparticle vaccine, in healthy Japanese participants.MethodsThis phase 1/2, randomized, observer-blind, placebo-controlled trial conducted in Japan (two sites), enrolled healthy Japanese adults aged ≥ 20 years with no history/risk of SARS-CoV-2 infection and no prior exposure to other approved/investigational SARS-CoV-2 vaccines or treatments. Participants were stratified by age (< 65 or ≥ 65 years) and randomized to receive two doses of either NVX-CoV2373 (5 μg SARS-CoV-2 rS; 50 μg Matrix-M1) or placebo, 21 days apart. Primary outcomes were safety and immunogenicity assessed by serum IgG antibody levels against SARS-CoV-2 rS protein on day 36. Herein, we report the primary data analysis at 4 weeks after the second dose, ahead of 12-month follow-up completion (data cut-off: 8 May 2021).ResultsBetween 12 February 2021 and 17 March 2021, 326 subjects were screened, and 200 participants enrolled and randomized: NVX-CoV2373, n = 150; placebo, n = 50. Solicited adverse events (AEs) through 7 days after each injection occurred in 121/150 (80.7%) and 11/50 (22.0%) participants in the NVX-CoV2373 and placebo arms, respectively. In the NVX-CoV2373 arm, tenderness and injection site pain were the most frequently reported solicited AEs after each vaccination, irrespective of age. Robust immune responses occurred with NVX-CoV2373 (n = 150) by day 36: IgG geometric mean fold rise (95% confidence interval) 259 (219, 306); seroconversion rate 100% (97.6, 100). No such response occurred with placebo (n = 49).ConclusionTwo doses of NVX-CoV2373 given with a 21-day interval demonstrated acceptable safety and induced robust anti-SARS-CoV-2 immune responses in healthy Japanese adults. Funding: Takeda Pharmaceutical Company Limited and Japan Agency for Medical Research and Development (AMED). ClinicalTrials.gov identifier: NCT04712110. 相似文献
38.
Alicia Julibert Maria del Mar Bibiloni Josep A. Tur 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(9):887-905
Background and aimsThe metabolic syndrome (MetS) is a cluster of coexisting cardiovascular risk factors. The role of specific dietary fats was reemphasized by dietary recommendations. This systematic review aims to assess evidence for the effect of dietary fat intake on MetS occurrence and reversion in adults.Methods and ResultsThe MEDLINE database was used to search the existing literature. We included observational studies that analyzed dietary fat intake in adults with MetS and clinical trials that compared the effects of different dietary fat diets on MetS and/or its components. Thirty articles were selected (14 observational and 16 clinical trials), and we included information of dietary fat and fatty acids as well as MetS, body mass index, cholesterol, hypertension, and diabetes in adults. SFA intake was found to be positively associated with MetS components. Most of the observational reviewed studies found beneficial associations between MUFA and PUFA (including n-3 and n-6 subtypes) intake and MetS components. Clinical trials also supported the benefits of MUFA- or PUFA-enriched diets (including low-fat diets) in reducing MetS.ConclusionsThe effects of dietary SFAs on MetS will be influenced by other specific nutrients. Replacement of SFA by MUFA and PUFA has been associated with a decrease in MetS. Dietary recommendations should emphasize on different qualities of fat intake, not only to reduce total fat intake, to obtain health benefits in adults. 相似文献
39.
40.
Sandeep Kumar Shukla Ajay Kumar Sharma Vanya Gupta M.H. Yashavarddhan 《Journal of tissue viability》2019,28(4):218-222
Wound inflammation is a rapid and highly orchestrated process that significantly impacts the wound healing cascade. Consequent to injury, a series of events set off that include inflammatory, proliferation and maturation phases leading to wound closure and restoration of normal skin integrity. Stimuli causing stress to host immune system or induce inflammatory response include tissue damage and pathogenic microbial infection.Several evidences points towards the positive role of inflammation as it essential to fight against the attack of invading pathogens and to remove dead tissues from the site of injury. Besides its positive role, prolonged inflammation is injurious and may result in deregulated stages of the wound healing which may lead to excessive scarring. Achieving balance in inflammatory cascade is one of the challenging tasks for development of a wound healing drug.This review mainly focuses on the pharmacological control of inflammation by agents which critically balance the inflammatory cascade. However, none of the agent is available in the healthcare market which exclusively plays a role in wound repair. In this review we shall explore different factors or agents affecting inflammation in wound healing. This information might be helpful in designing and development new process, technologies or drugs for better management of wound care. In addition, understanding the effect of inflammation on the outcome of the healing process will serve as a significant milestone in the area of pathological tissue repair. 相似文献